Skip to content

Elaine Sullivan

Independent Non-Executive Director

Dr Elaine Sullivan is a Senior pharmaceutical and biotech industry executive with a successful track record in science, investment, business development, and start-ups
hvivo-elaine-sullivan

Experience

Dr Elaine Sullivan is a Senior pharmaceutical and biotech industry executive with a successful track record in science, investment, business development, and start-ups with over 25 years’ experience.

She has extensive global leadership experience including membership of the top senior global R&D management teams at Eli Lilly (US) where she held the position of Vice President Global External Research & Development, and she was a member of Lilly Ventures and Lilly Asian Venture steering Committee. At AstraZeneca (UK) she held a number of positions including Vice President R&D, Head of New Opportunities Therapy Area and Vice President, Science & Technology.

Former positions also include positions co-founder and CEO of Carrick Therapeutics. Her board appointments include Member of the Supervisory Board of Evotec AG, Non-Executive Director of the IP Group plc, hVIVO plc, Zealand Pharmaceuticals and Nykode Therapeutics ASI where she is also the Chair of the R&D committee.

In addition, Elaine is a member of the Scientific Advisory board of Poolbeg Pharma. She was named Ernst Young Emerging Entrepreneur of the Year (Ireland) Executed external risk share partnerships, to access to global innovation while balancing scientific and financial risk. member of the steering and investment boards of Capital Funds, Lilly Ventures, and Lilly Asian Ventures.

Former positions include Co-founder and CEO of Carrick Therapeutics raised $95 million Series A. Vice-President R&D, Head of New Opportunities Therapy Area (AstraZeneca, UK), creating additional value from the AstraZeneca portfolio by repositioning molecules to other diseases and entering new therapy areas/diseases via spinouts, joint ventures, strategic partnerships, and acquisitions.

Delivered over 250 collaborations and transactions including spinouts, joint ventures, strategic partnerships and multi-million US$ acquisitions. Extensive experience in executing deals world-wide including US, Europe, and China. Worked globally in US and Europe. Winner of the Ernst Young Emerging Entrepreneur of the Year (Ireland).

Contributed Articles

View all Resources
Case StudyScientific PublicationFactsheetBlog

A New Frontier in Respiratory Health: Next-Gen Human Challenges Explained

Case StudyScientific PublicationFactsheetBlog

Beyond Traditional Studies: The New Era of Respiratory Virus Human Challenge Models

Scientific PublicationFactsheetBlog

The Future of Virology: How Next-Gen Human Challenge Models are Breaking Barriers